Novoray Corp
SSE:688300
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
30.61
69.76
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Net Margin
Novoray Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 12.1B CNY |
| Net Margin |
26%
|
| Country | SA |
| Market Cap | 228.3B SAR |
| Net Margin |
1%
|
| Country | ID |
| Market Cap | 43.8B USD |
| Net Margin |
-4%
|
| Country | ID |
| Market Cap | 633.7T IDR |
| Net Margin |
-4%
|
| Country | US |
| Market Cap | 28.1B USD |
| Net Margin |
2%
|
| Country | UK |
| Market Cap | 24.1B USD |
| Net Margin |
5%
|
| Country | CN |
| Market Cap | 109B CNY |
| Net Margin |
3%
|
| Country | US |
| Market Cap | 14.8B USD |
| Net Margin |
1%
|
| Country | KR |
| Market Cap | 19.8T KRW |
| Net Margin |
1%
|
| Country | CN |
| Market Cap | 87.8B CNY |
| Net Margin |
1%
|
| Country | IN |
| Market Cap | 921.1B INR |
| Net Margin |
16%
|
Novoray Corp
Glance View
In the bustling landscape of modern technology companies, Novoray Corp has carved out a niche with its cutting-edge solutions in the realm of imaging and radiography technology. Founded by a group of visionary engineers and entrepreneurs, Novoray emerged from the need to innovate within medical and industrial sectors. The company has honed its expertise in developing advanced imaging systems that harness the power of digital radiography and computed tomography. These systems find applications in diverse fields ranging from healthcare diagnostics to industrial non-destructive testing, offering unparalleled clarity and precision. Novoray's commitment to research and development is evident in its consistently innovative product lineup, attracting a loyal clientele composed of hospitals, manufacturing units, and research institutions worldwide. At the heart of Novoray's business model lies its multi-faceted revenue streams. The company generates income by selling state-of-the-art imaging equipment, complemented by service contracts for maintenance and upgrades, ensuring clients have continuous access to the latest technology. Beyond hardware sales, Novoray has strategically boosted its recurring revenue through software solutions that enhance image processing and diagnostics. This software-as-a-service (SaaS) approach facilitates smooth integration into clients' existing systems, driving efficiency and improving outcomes. Additionally, Novoray capitalizes on training and consultancy services, empowering clients to leverage their technology to its full potential. Through these various avenues, Novoray Corp not only sustains its financial health but also secures a reputation as a leader in precision imaging solutions.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Novoray Corp's most recent financial statements, the company has Net Margin of 26.2%.
You don't have any saved screeners yet
